Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function

NCT04556461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Tralokinumab

Sponsor

Prof. Dr. Stephan Weidinger